Genentech

Affimed and Roche ink $5bn plus cancer immunotherapy deal

https://pharmaphorum.com/news/affimed-and-roche-ink-5bn-plus-cancer-immunotherapy-deal/

Breakthrough designation for Roche/Novartis’ Xolair in food allergies

https://pharmaphorum.com/news/breakthrough-designation-for-roche-novartis-xolair-in-food-allergies/

Genentech’s Rituxan approved for rare skin disease

https://pharmaphorum.com/news/genentechs-rituxan-rare-skin-disease/

Calling all Microbiologists – 5 great reasons to be in San Diego

https://pharmaphorum.com/partner-content/calling-all-microbiologists-5-great-reasons-to-be-in-san-diego/

Hear from Genentech and Cristalia Produtos Quimicos Farmaceuticos

https://pharmaphorum.com/partner-content/hear-from-genentech-and-cristalia-produtos-quimicos-farmaceuticos-2/

Hear from Genentech and Cristalia Produtos Quimicos Farmaceuticos

https://pharmaphorum.com/partner-content/hear-from-genentech-and-cristalia-produtos-quimicos-farmaceuticos/

Roche and AC Immune’s Alzheimer’s drug on right track

https://pharmaphorum.com/news/rochegenentechs-alzheimers/

Three’s a crowd as Tecentriq approved in lung cancer

https://pharmaphorum.com/news/roches-tecentriq-approved-lung-cancer/

Genentech’s Xolair gets US paediatric use

https://pharmaphorum.com/news/genentechnovartis-xolair-gets-us-paediatric-use/

1 2

Close in 10 seconds

Pharmaphorum.com

Search